AKT Inhibitors
본문
AKT Inhibitors
Product Name: Akt Inhibitor VIII, Isozyme-Selective,  Akti-1/2

A cell-permeable  quinoxaline compound that potently and selectively inhibits Akt1/Akt2  activity (IC50 = 58 nM, 210 nM, and 2.12 µM for Akt1, Akt2, and  Akt3, respectively, in in vitro kinase assays). The inhibition appears  to be pleckstrin homology 
(PH) domain-dependent. It does not exhibit any  inhibitory effect against PH domain-lacking Akts, or other closely related  
AGC family kinases, PKA, PKC, and SGK, even at concentrations as high as 50   µM. Overcomes Akt1/Akt2-mediated resistance to chemotherapeutics in tumor  cells and is shown to block basal and stimulated phosphorylation/activation  of Akt1/Akt2 both in cultured cells in vitro and in mice in vivo.
Details
| 
             Chemical Formula: 
         | 
        
             | 
        
             C34H29N7O 
         | 
    
| 
             CAS No.: 
         | 
        
             | 
        
             612847-09-3 
         | 
    
| 
             Molecular weight: 
         | 
        
             | 
        
             551.6 
         | 
    
| 
              Purity: 
         | 
        
             | 
        
             98% by HPLC 
         | 
    
| 
             Appearance: 
         | 
        
             | 
        
             Light yellow solid 
         | 
    
| 
              Chemical name:  
         | 
        
             | 
        
              1,3-Dihydro-1-(1-((4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl)methyl)-4- piperidinyl)-2H-benzimidazol-2-one 
         | 
    
| 
             Solubility: 
         | 
        
             | 
        
             DMSO (5mg/mL) 
         | 
    
| 
              Storage:  
         | 
        
             | 
        
             Protect from light. Packaged under inert gas 
         | 
    
References

A cell-permeable, reversible, and selective inhibitor of the phosphorylation of Akt and its in vitro kinase activity (complete 
inhibition < 5 µM) with minimal effect on PI 3-K, PDK1, or SGK1. Shown to suppress growth of Rh (rhabdomyosarcoma) cell 
lines (IC50 = 2-5 μM), inhibit IGF-I-stimulated nuclear translocation of Akt, and prevent phosphorylation of the downstream 
targets, mTOR, p70S6 kinase, and S6 ribosomal protein. Unlike Akti1/2 (Cat # CD0223), the mode of inhibition is not PH 
domain-dependent. Also shown to induce neuronal autophagy in an Akt- and mTOR-independent manner and enhances the 
clearance of misfolded protein.
Details
| 
             Chemical Formula: 
         | 
        
             | 
        
             C20H25CIN2O∙HCI 
         | 
    
| 
             CAS No.: 
         | 
        
             | 
        
             925681-41-0 
         | 
    
| 
             Molecular weight: 
         | 
        
             | 
        
             381.4 
         | 
    
| 
              Purity: 
         | 
        
             | 
        
             98% by HPLC 
         | 
    
| 
             Appearance: 
         | 
        
             | 
        
              White solid 
         | 
    
| 
              Chemical name:  
         | 
        
             | 
        
              10-(4′-(N-diethylamino)butyl)-2-chlorophenoxazine hydrochloride 
         | 
    
| 
             Solubility: 
         | 
        
             | 
        
             DMSO (60 mg/mL), water (1 mg/mL) 
         | 
    
| 
              Storage:  
         | 
        
             | 
        
             Protect from light. Packaged under inert gas 
         | 
    
References
Ordering informations
| 
             Catalog No. 
         | 
        
             Product Name 
         | 
        
             Size 
         | 
    
| 
             CD0223 
         | 
        
             AKT inhibitor VIII 
         | 
        
             1mg, 5mg, 10mg & 25mg 
         | 
    
| 
             CD0225 
         | 
        
             AKT inhibitor X 
         | 
        
             1mg, 5mg, 10mg & 25mg 
         | 
    
댓글목록
등록된 댓글이 없습니다.